文献
J-GLOBAL ID:201802241507101000
整理番号:18A1207637
レニン-アンギオテンシン系の阻害剤の標的用量を受ける2型糖尿病および慢性心不全患者における腎機能に対するネプリリシン阻害の効果:パラダイム-HF試験の二次分析【JST・京大機械翻訳】
Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial
著者 (7件):
Packer Milton
(Baylor Heart and Vascular Hospital, Baylor University Medical Center, Dallas, TX, USA)
,
Claggett Brian
(Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, MA, USA)
,
Lefkowitz Martin P
(Novartis, Basel, Switzerland)
,
McMurray John J V
(BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK)
,
Rouleau Jean L
(Institut de Cardiologie de Montreal, University of Montreal, Montreal, QC, Canada)
,
Solomon Scott D
(Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, MA, USA)
,
Zile Michael R
(Medical University of South Carolina and Ralph H Johnson Veterans Administration Medical Center, Charleston, SC, USA)
資料名:
Lancet Diabetes & Endocrinology
(Lancet Diabetes & Endocrinology)
巻:
6
号:
7
ページ:
547-554
発行年:
2018年
JST資料番号:
W3110A
ISSN:
2213-8587
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)